MELBOURNE, GENEVA, and NEW YORK – June 13, 2018 — Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) announced today that the United States (U.S.)…Original Article
FDA Approves Moxidectin for the Treatment of River Blindness
